| Structure |
Chemical Name |
CAS |
MF |
 |
Caspofungin impurity E |
|
|
 |
Cefodizime Impurity 4 |
|
|
 |
Nemonoxacin |
378746-64-6 |
C20H25N3O4 |
 |
Nitrendipine iMpurity F |
|
|
 |
フェノフィブリン酸1,1-ジメチル-2-(1-メチルエトキシ)-2-オキソエチルエステル |
217636-48-1 |
C24H27ClO6 |
aMino]Methyl]-3-nitro-4-(phenylMethoxy)benzeneMethanol](/CAS/20180808/GIF/43229-67-0.gif) |
α-[[[2-(4-Methoxyphenyl)-1-Methylethyl](phenylMethyl)aMino]Methyl]-3-nitro-4-(phenylMethoxy)benzeneMethanol |
43229-67-0 |
C32H34N2O5 |
 |
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
 |
クロルヘキシジン二塩酸塩不純物B |
1308292-89-8 |
C16H26ClN9O |
![Carbamic acid, N-[(4-methylphenyl)sulfonyl]-](/CAS/20200331/GIF/107628-27-3.gif) |
Carbamic acid, N-[(4-methylphenyl)sulfonyl]- |
107628-27-3 |
C8H9NO4S |
![8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one](/CAS/20180703/GIF/869478-13-7.gif) |
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
 |
Oseltamivir Impurity 33 |
|
|
 |
Riociguat IMpurtiy C |
|
|
 |
Atomoxetine EP Impurity F |
|
|
![3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]-](/CAS/20210305/GIF/2474774-17-7.gif) |
3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]- |
2474774-17-7 |
C15H19NO3 |
 |
Canagliflozin Peroxide Impurity |
2247196-28-5 |
C24H25FO7S |
![1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI)](/CAS/20200515/GIF/21788-37-4.gif) |
1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI) |
21788-37-4 |
C10H16N2O3S |
 |
Avatrombopag Impurity 64 |
|
|
 |
Olaparib Impurity P |
|
|
 |
Tafluprost Impurity 17 |
|
|
 |
1H-Benzimidazole-2-sulfinicacid(9CI) |
58536-71-3 |
C7H6N2O2S |
 |
Diquafosol Impurity E |
|
|
 |
Carbonic acid, dichloromethyl methyl ester |
207804-63-5 |
C3H4Cl2O3 |
 |
Reference Material for the Calibration of Urine Analyzer |
|
|
 |
Tadalafil Impurity 35 |
749864-17-3 |
C20H18N2O4 |
![(R)-1-chloro-3-{[(4-chlorophenyl)methylene]amino}propan-2-ol](/CAS/20180601/GIF/1450915-93-1.gif) |
(R)-1-chloro-3-{[(4-chlorophenyl)methylene]amino}propan-2-ol |
1450915-93-1 |
C10H11Cl2NO |
 |
Capecitabine Impurity 9 |
|
|
![Glycine, N-[4-(aminocarbonyl)phenyl]-](/CAS/20200401/GIF/355809-32-4.gif) |
Glycine, N-[4-(aminocarbonyl)phenyl]- |
355809-32-4 |
C9H10N2O3 |
 |
Rabeprazole Impurity 2 |
1807988-36-8 |
C18H19N3O4 |
 |
Hispidulin 4'-O-β-D-glucopyranoside |
244285-12-9 |
C22H22O11 |
 |
Diazepam Impurity 3 |
176796-46-6 |
C17H17ClN2O2 |
![4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester](/CAS/20180703/GIF/1941177-45-2.gif) |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
 |
N - hydroxy Tropisetron Impurity 2 |
|
|
 |
Benzenepropanoic acid, 4-(2-oxiranylmethoxy)- |
2167848-51-1 |
C12H14O4 |
 |
PANTOPRAZOLE SULFONE N-OXIDE |
953787-55-8 |
C16H15F2N3O6S |
 |
Pregabalin Impurity 6 |
2102350-92-3 |
C9H15NO3 |
 |
Rosuvastatin Impurity 143 |
2964549-48-0 |
C32H34F2N6O7S2 |
 |
N-エチル-N-メチルカルバモイルクロリド |
42252-34-6 |
C4H8ClNO |
 |
Acetamide, 2-(diethylamino)-N-(3,4-dimethylphenyl)- |
3213-16-9 |
C14H22N2O |
 |
(S)-Baclofen-d4 |
|
|
 |
Cefathiamidine Impurity 4 |
1418224-75-5 |
C10H11BrN2O5S |
 |
Bimatoprost Impurity 23 |
|
|
 |
Moxifloxacin Impurity 44 |
1048972-52-6 |
C14H12FNO5 |
 |
ent-Ivabradine Hydrochloride |
148849-68-7 |
C27H37ClN2O5 |
 |
Sitagliptin Impurity 24 |
2349567-54-8 |
C15H19F2NO4 |
 |
Tegoprazan Impurity 4 |
|
|
 |
4,5-dichloro Rivaroxaban |
2305917-61-5 |
C25H28ClN3O6S |
 |
Fexofenadine Impurity 12 |
1010812-98-2 |
C32H37NO4 |
 |
Cabozantinib impurity 1DYH |
1621681-63-7 |
C28H24FN3O6 |
 |
Pemetrexed Impurity 51 |
|
|
 |
Lenvatinib Impurity LFZZ-8 |
|
C44H40Cl2N8O8 |
 |
Crisaborole Impurity |
906673-42-5 |
C14H10BNO3 |
 |
Cabozantinib Impurity 47 |
113136-79-1 |
C11H10ClNO3 |
 |
1(3H)-Isobenzofuranone, 3-(1-methylpropyl)- |
261783-87-3 |
C12H14O2 |
 |
Oxacillin sodium Impurity E |
|
|
![12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate](/CAS/20180703/GIF/176515-52-9.gif) |
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
 |
Org49095 |
2412952-95-3 |
C71H111NaO48S8 |
 |
IverMectin B1 Mono-sugar Derivative |
71837-27-9 |
C41H62O11 |
 |
Verapamil Impurity O |
959011-16-6 |
C27H38N2O4 |
![2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole](/CAS/20150408/GIF/142384-07-4.gif) |
2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole |
142384-07-4 |
C14H12N4O3S |
 |
Aprepitant Impurity 32 |
|
|
 |
Formoterol Impurity 4 |
|
|
 |
Ertapenem Impurity I(USP) |
|
|
 |
Erlotinib Impurity 50 |
|
|
 |
Cefuroxime Sodium Impurity |
|
C16H16N4NaO8S |
 |
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
 |
N-Desisopropyl-N-forMyl Bisoprolol |
1346602-59-2 |
C16H25NO5 |
 |
1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione |
61919-52-6 |
C20H26O3 |
 |
Nintedanib Impurity N |
|
|
 |
Linagliptin Impurity I |
|
|
 |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid |
2101641-92-1 |
C7H13BrO2 |
 |
Palbociclib-d8 |
1628752-83-9 |
C24H21D8N7O2 |
 |
Riociguat IMpurtiy B |
|
|
 |
Fosaprepitant Impurity 12 |
172673-19-7 |
C23H22F7N4O6P |
 |
Budesonide Impurity 7 |
3949-79-9 |
C23H28O7 |
 |
4-(オキシラニルメトキシ)ベンゼンアセトアミド |
29122-69-8 |
C11H13NO3 |
 |
4-((2-amino-3,5-dibromobenzyl)amino)cyclohexanone hydrochloride |
|
C13H17Br2ClN2O |
![(6R,7R)-7-[(2,2-dimethylpropanoyl)amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/20180703/GIF/CB43155163.gif) |
(6R,7R)-7-[(2,2-dimethylpropanoyl)amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
2384108-14-7 |
C16H20N4O4S3 |
 |
SPLASH? LIPIDOMIX? Mass Spec Standard |
|
|
 |
Moxifloxacin Impurity 15 |
|
|
 |
Rocuronium Bromide Impurity 39 |
|
|
 |
Ciprofloxacin EP Impurity E |
879005-96-6 |
C16H20FN3O |
 |
Canagliflozin Impurity 42 |
|
|
 |
Rocuronium Bromide Impurity 38 |
|
|
 |
4-(4-フルオロフェニル)-1-メチル-1,2,3,6-テトラヒドロピリジン塩酸塩 |
1012886-75-7 |
C12H15ClFN |
 |
Sugammadex sodium Org199010-1 Impurity |
|
|
 |
Atracurium Impurity S |
|
|
![Diaquo[(1R,2R)-1,2-cyclohexanediaMine]platinuM DiMer Dinitrate](/CAS/GIF/82398-34-3.gif) |
Diaquo[(1R,2R)-1,2-cyclohexanediaMine]platinuM DiMer Dinitrate |
82398-34-3 |
C12H24N5O5Pt2+ |
 |
2-(MethylcarbaMoyl)benzoic acid |
6843-36-3 |
C9H9NO3 |
 |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
2304623-36-5 |
C16H14N2O3S |
![3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2-[1-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]pentan-2-yl]-1,3-diazaspiro[4.4]non-1-en-4-one](/CAS/20180601/GIF/1346598-52-4.gif) |
3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2-[1-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]pentan-2-yl]-1,3-diazaspiro[4.4]non-1-en-4-one |
1346598-52-4 |
C39H38N10O |
 |
Canagliflozin Impurity 61 |
|
|
 |
CIS-モンテルカスト |
774538-96-4 |
C35H36ClNO3S |
 |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
 |
(S,E)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxyhept-2-enoic acid calcium(II) |
1659317-57-3 |
C33H35CaFN2O4 |
 |
RV Salmonella enrichment broth (Pharmacopoeia 2015 edition) |
|
|
 |
Olaparib Impurity A |
|
|
 |
Mono-Hydroxy Sugammadex |
2376607-99-5 |
C69H109NaO47S7 |
 |
Desethanol Dipyridamole |
1176886-12-6 |
C22H36N8O3 |
![トルセミド関連化合物B (N-[(N-ブチルアミノ)カルボニル]-4-[(3-メチルフェニル)アミノ]-3-ピリジンスルホンアミド)](/CAS/GIF/160972-33-8.gif) |
トルセミド関連化合物B (N-[(N-ブチルアミノ)カルボニル]-4-[(3-メチルフェニル)アミノ]-3-ピリジンスルホンアミド) |
160972-33-8 |
C17H22N4O3S |
 |
Ganciclovir Dipropionate |
86357-20-2 |
C15H21N5O6 |